Filings
Finds words inside filing documents. Searching Oncotelic Therapeutics, Inc.'s filings · 39 documents indexed.
6 documents · 37 matches
-
OTLC Oncotelic Therapeutics, Inc. 10-Q 2025-08-13
Item 1 · Note 1. Description of Business and Basis of Presentation
going concern. The Company has incurred net accumulated losses of approximately $38.1 million since inception of Oncotelic Inc., as the Company6 matches in this document -
OTLC Oncotelic Therapeutics, Inc. 10-Q 2026-08-13
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
going concern. The financial statements contained in this report do not include any adjustments related to the recoverability of assets5 matches in this document -
OTLC Oncotelic Therapeutics, Inc. 10-Q 2026-05-14
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
going concern. The financial statements contained in this report do not include any adjustments related to the recoverability of assets5 matches in this document -
OTLC Oncotelic Therapeutics, Inc. 10-K 2026-04-15
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
going concern. The financial statements contained in this report do not include any adjustments related to the recoverability of assets8 matches in this document -
OTLC Oncotelic Therapeutics, Inc. 10-Q 2025-11-17
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
going concern. The financial statements contained in this report do not include any adjustments related to the recoverability of assets7 matches in this document -
OTLC Oncotelic Therapeutics, Inc. 10-Q 2025-05-15
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
going concern. The financial statements contained in this report do not include any adjustments related to the recoverability of assets6 matches in this document
Page 1 of 1 · 6 documents